Anbio Biotechnology (NNNN)
NASDAQ: NNNN · Real-Time Price · USD
11.59
+1.44 (14.19%)
At close: Jul 29, 2026, 4:00 PM EDT
11.99
+0.40 (3.45%)
Pre-market: Jul 30, 2026, 4:07 AM EDT
Anbio Biotechnology Market Cap
Anbio Biotechnology has a market cap or net worth of $508.7 million as of July 30, 2026. Its market cap has decreased by -77.20% in one year.
Market Cap
508.70M
Enterprise Value
496.80M
1-Year Change
-77.20%
Ranking
Category
Stock Price
$11.59
ChartMarket Cap Chart
Since the IPO on February 19, 2025, Anbio Biotechnology's market cap has increased from $219.46M to $508.70M, an increase of 131.80%. That is a compound annual growth rate of 79.41%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 29, 2026 | 508.70M | -61.46% |
| Dec 31, 2025 | 1.32B | 501.40% |
| Feb 19, 2025 | 219.46M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Kestra Medical Technologies | 1.33B |
| Azenta | 1.27B |
| STAAR Surgical Company | 1.15B |
| Anteris Technologies Global | 798.16M |
| AngioDynamics | 569.15M |
| OraSure Technologies | 273.33M |
| Sanara MedTech | 238.26M |
| Utah Medical Products | 220.95M |